tradingkey.logo

CytomX Therapeutics Provides Update On CX-2051 Phase 1 Study

ReutersAug 13, 2025 12:01 PM

- CytomX Therapeutics Inc CTMX.O:

  • CYTOMX THERAPEUTICS PROVIDES UPDATE ON CX-2051 PHASE 1 STUDY

  • CYTOMX THERAPEUTICS INC - CTMX-2051-101 STUDY REMAINS ACTIVE WITH CX-2051 DOSING

  • CYTOMX THERAPEUTICS INC - PHASE 1 DATA UPDATE EXPECTED BY Q1 2026

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI